Alternatives to Tharimmune
Tharimmune is a Biotech tool: biotechnology company developing novel immunotherapies for cancer. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Tharimmune
- Website
Bristol Myers Squibb22BiotechNew York, United StatesA global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.
- Website
Gilead SciencesBiotechFoster City, United StatesBiopharmaceutical company focused on developing and commercializing innovative medicines.
- Website
ImmunoScape58BiotechnologySingapore, Singapore$49.7MDeveloping novel immunotherapies and diagnostics for cancer.
- Website Aptevo Therapeutics Inc.17BiotechSeattle, United States
A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.
- Website
Brenus Pharma48BiotechnologyLyon, France$12.6MClinical-stage immunotherapy company developing novel treatments for cancer.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Ella Therapeutics47Life SciencesBoston, United StatesDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
- Website
Umlaut.bio35BiotechnologyCambridge, USA$3.0MDeveloping novel immunotherapies for cancer.
- Website
BeiGene65BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
- Website
Leap Therapeutics50BiotechCambridge, United States$189.0MLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
- Website
C4 Therapeutics49BiotechBoston, United States$371.0MBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
- Website
MacroGenics49BiotechRockville, United States$13.5MBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website LELeman Biotech48BiotechShenzhen, China$22.7M
Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
Showing the 20 closest matches. See the rest on the Tharimmune profile.